Ayala Pharmaceuticals Inc (fka ADXS)

[jckrdu]

I hear you. Ken has to balance the short term cash needs with any longer-term gameplan he may want to execute, so I agree some type of licensing in next 3-6 months may be coming to raise at least a little cash. A combination approach of near-term licensing with some amount of upfront cash, combined with some moderate dilution may be the path forward.

September call will be interesting.